These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8150753)

  • 21. Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.
    Abd El-Aty AM; Goudah A; Mouneir SM; Sunwoo YE; Jang JH; Shin JG; Shim JH; Shimoda M
    Vet Res Commun; 2007 Jan; 31(1):67-75. PubMed ID: 17186405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration-time courses of pefloxacin in plasma and milk of lactating she-camels (Camelus dromedarius).
    Goudah A; Shah SS; Shin HC; Chang BJ; Shim JH; Abd El-Aty AM
    Berl Munch Tierarztl Wochenschr; 2008; 121(11-12):432-9. PubMed ID: 19086693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of FCE 22101 in man following different modes of administration.
    Lovering AM; White LO; Lewis DA; MacGowan AP; Routh KR; Pickin DM; Reeves DS
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():179-95. PubMed ID: 2732141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis.
    Arguedas AG; Stutman HR; Zaleska M; Knupp CA; Marks MI; Nussbaum E
    Am J Dis Child; 1992 Jul; 146(7):797-802. PubMed ID: 1496945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetic profile of a new generation of parenteral cephalosporin.
    Rybak M
    Am J Med; 1996 Jun; 100(6A):39S-44S. PubMed ID: 8678096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic population study to describe cefepime lung concentrations.
    Breilh D; Saux MC; Delaisement C; Fratta A; Ducint D; Velly JF; Couraud L
    Pulm Pharmacol Ther; 2001; 14(2):69-74. PubMed ID: 11273786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefepime clinical pharmacokinetics.
    Okamoto MP; Nakahiro RK; Chin A; Bedikian A
    Clin Pharmacokinet; 1993 Aug; 25(2):88-102. PubMed ID: 8403741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses.
    Guglick MA; MacAllister CG; Clarke CR; Pollet R; Hague C; Clarke JM
    Am J Vet Res; 1998 Apr; 59(4):458-63. PubMed ID: 9563631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cefepime in patients with respiratory tract infections.
    Kovarik JM; ter Maaten JC; Rademaker CM; Deenstra M; Hoepelman IM; Hart HC; Matzke GR; Verhoef J
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1885-8. PubMed ID: 2291655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.
    Rhodes NJ; Grove ME; Kiel PJ; O'Donnell JN; Whited LK; Rose DT; Jones DR; Scheetz MH
    Int J Antimicrob Agents; 2017 Sep; 50(3):482-486. PubMed ID: 28668694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
    Barbhaiya RH
    Biopharm Drug Dispos; 1996 May; 17(4):319-30. PubMed ID: 8743403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous administration of cefepime.
    Walker P; Neuhauser MN; Tam VH; Willey JS; Palmer JL; Bruera E; Prince RA
    J Pain Symptom Manage; 2005 Aug; 30(2):170-4. PubMed ID: 16125032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ticarcillin and ticarcillin-probenecid in sheep.
    Errecalde JO; Lanusse CE; Mestorino ON; Landoni MF; Soraci AL
    Zentralbl Veterinarmed A; 1991 May; 38(4):255-60. PubMed ID: 1907783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
    Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
    Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma, urine and skin pharmacokinetics of cefepime in burns patients.
    Sampol E; Jacquet A; Viggiano M; Bernini V; Manelli JC; Lacarelle B; Durand A
    J Antimicrob Chemother; 2000 Aug; 46(2):315-7. PubMed ID: 10933661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.